Shortcut Navigation:

Breast Cancer News

In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.

Benefit of mammograms even greater than thought

June 28, 2011

CHICAGO (Reuters) - The longest-running breast cancer screening study ever conducted has shown that regular mammograms prevent deaths from breast cancer, and the number of lives saved increases over time, an international research team said on Tuesday.

U.S. hears Roche on Avastin for breast cancer

June 28, 2011

SILVER SPRING, Md. (Reuters) - Breast cancer patients testified that Roche Holding AG's drug Avastin saved their lives as U.S. health officials consider whether the world's best-selling cancer drug should still be approved for that condition.

Some success seen with personalized cancer treatment

June 3, 2011

CHICAGO (Reuters) - Tailoring cancer drugs to target the molecular signature of an individual patient's tumor helps more than a scattershot approach, according to early-stage research.

Beta-blockers tied to breast cancer survival

May 31, 2011

NEW YORK (Reuters Health) - Women with breast cancer who take common blood pressure drugs may have better odds of surviving the disease, according to two preliminary studies.

New breast cancer guidelines 'unsafe': women

May 27, 2011

NEW YORK (Reuters Health) - More than eight out of 10 women say new guidelines recommending against routine breast cancer screening of women under 50 are "unsafe," according to a small survey.

Obesity Impacts Breast Cancer Survival

May 25, 2011

Researchers found an association between obesity at diagnosis and overall survival in women with hormone-sensitive breast cancer, reports a study presented at the San Antonio Breast Cancer Symposium.

Short wait for breast cancer surgery seems safe

May 25, 2011

NEW YORK (Reuters Health) - Women newly diagnosed with earlier-stage breast cancer can take a few weeks to prepare for surgery without raising the odds that their tumor will progress, a new study suggests.

Women with high co-pays prone to stop cancer drug

May 25, 2011

NEW YORK (Reuters Health) - Women taking breast cancer drugs are more likely to skip days or drop the treatment entirely if their co-pay is high, U.S. researchers have found.

FDA Invites Comments on Avastin

May 11, 2011

FDA officials have invited the public to testify at a hearing that will argue the merits of bevacizumab (Avastin) as an approved treatment for HER2 negative metastatic breast cancer.

NCCN Updates Metastatic Guidelines

April 5, 2011

The National Comprehensive Cancer Network’s updated clinical practice guidelines for metastatic breast cancer retain bevacizumab as a treatment option and add two new therapies, the chemotherapy medicine eribulin and the RANKL inhibitor denosumab.

Denver, CO  ·  September 13, 2014

Join Your Community for Yoga on the Steps!

Close
close